AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] DaVita Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) filed an 8-K disclosing its ninth one-month extension to complete a business combination. The Board moved the deadline, known as the “Business Combination Period,� from 5 Aug 2025 to 5 Sep 2025.

To effect the extension, sponsor CGC II Sponsor LLC will advance $250,000 under an unsecured promissory note that permits borrowings up to $2.4 million. The funds will be deposited into the IPO trust account as required by the company’s amended memorandum and articles.

This is the 9th of 12 permissible monthly extensions; no additional financial results, target identification, or other material transactions were reported.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) ha presentato un modulo 8-K annunciando la nona proroga di un mese per completare una combinazione aziendale. Il Consiglio ha spostato la scadenza, nota come “Periodo di Combinazione Aziendale,� dal 5 agosto 2025 al 5 settembre 2025.

Per attuare la proroga, lo sponsor CGC II Sponsor LLC anticiperà 250.000 dollari tramite una nota di debito non garantita che consente prestiti fino a 2,4 milioni di dollari. I fondi saranno depositati nel conto fiduciario IPO come richiesto dal memorandum e dallo statuto modificati della società.

Questa è la 9ª delle 12 proroghe mensili consentite; non sono stati comunicati nuovi risultati finanziari, identificazione di target o altre operazioni rilevanti.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) presentó un formulario 8-K informando sobre su novena prórroga de un mes para completar una combinación de negocios. La Junta movió la fecha límite, conocida como el “Período de Combinación de Negocios,� del 5 de agosto de 2025 al 5 de septiembre de 2025.

Para efectuar la prórroga, el patrocinador CGC II Sponsor LLC adelantará 250,000 dólares bajo una nota promisoria no garantizada que permite préstamos de hasta 2.4 millones de dólares. Los fondos se depositarán en la cuenta fiduciaria de la IPO según lo requerido por el memorando y los estatutos enmendados de la compañía.

Esta es la 9ª de 12 prórrogas mensuales permitidas; no se reportaron nuevos resultados financieros, identificación de objetivos u otras transacciones materiales.

Cartesian Growth Corporation II (나스ë‹�: RENE/RENEU/RENEW)ê°€ 사업 ê²°í•© 완료ë¥� 위한 아홉 번째 í•� ë‹� 연장 사실ì� 8-K 보고서로 공시했습니다. ì´ì‚¬íšŒëŠ” ‘사ì—� ê²°í•© 기간â€� 마ê°ì¼ì„ 2025ë…� 8ì›� 5ì¼ì—ì„� 2025ë…� 9ì›� 5ì¼ë¡œ 연기했습니다.

연장ì� 실행하기 위해 스í°ì„� CGC II Sponsor LLCëŠ� 최대 240ë§� 달러까지 차입ì� 가능한 무담ë³� 약ì†ì–´ìŒìœ¼ë¡œ 25ë§� 달러ë¥� 선지급할 예정입니ë‹�. ì� ìžê¸ˆì€ 회사ì� 수정ë� ì •ê´€ ë°� ê°ì„œì—� ë”°ë¼ IPO ì‹ íƒê³„좌ì—� 입금ë©ë‹ˆë‹�.

ì´ë²ˆì� 허용ë� 12íš� ì¤� 9번째 월별 연장입니ë‹�; 추가 재무 ê²°ê³¼, 목표 ì‹ë³„ ë˜ëŠ” 기타 중요í•� 거래ëŠ� ë³´ê³ ë˜ì§€ 않았습니ë‹�.

Cartesian Growth Corporation II (Nasdaq : RENE/RENEU/RENEW) a déposé un formulaire 8-K révélant sa neuvième prolongation d’un mois pour finaliser une fusion d’entreprise. Le conseil d’administration a repoussé la date limite, appelée « Période de Fusion », du 5 août 2025 au 5 septembre 2025.

Pour effectuer cette prolongation, le sponsor CGC II Sponsor LLC avancera 250 000 dollars via un billet à ordre non garanti autorisant des emprunts jusqu’� 2,4 millions de dollars. Les fonds seront déposés sur le compte fiduciaire de l’IPO conformément au mémorandum et aux statuts modifiés de la société.

Il s’agit de la 9e des 12 prolongations mensuelles autorisées ; aucun résultat financier supplémentaire, identification de cible ou autre transaction importante n’a été rapporté.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) hat einen 8-K-Bericht eingereicht, in dem die neunte einmonatige Verlängerung zur Durchführung einer Unternehmenszusammenführung bekanntgegeben wird. Der Vorstand verschob die Frist, bekannt als „Business Combination Period�, vom 5. August 2025 auf den 5. September 2025.

Zur Durchführung der Verlängerung wird der Sponsor CGC II Sponsor LLC 250.000 US-Dollar über einen ungesicherten Schuldschein vorschießen, der Darlehen bis zu 2,4 Millionen US-Dollar erlaubt. Die Mittel werden auf das IPO-Treuhandkonto eingezahlt, wie es durch die geänderte Satzung des Unternehmens vorgeschrieben ist.

Dies ist die 9. von 12 zulässigen monatlichen Verlängerungen; keine weiteren Finanzergebnisse, Zielidentifikationen oder sonstigen wesentlichen Transaktionen wurden gemeldet.

Positive
  • Sponsor advances $250,000 to fund the trust, signaling ongoing financial support.
  • Trust account remains intact, preserving redemption value for public shareholders.
Negative
  • Ninth extension highlights continued inability to secure a merger target, increasing deal uncertainty.
  • Additional borrowing under the $2.4 million note raises leverage ahead of any future transaction.

Insights

TL;DR � Ninth extension keeps SPAC alive but signals difficulty closing a deal; sponsor support limits immediate redemption risk.

Another one-month extension to 5 Sep 2025 indicates CGC II has yet to secure a definitive merger agreement. The sponsor’s $250k deposit demonstrates continued financial backing, protecting the trust value and meeting charter requirements. However, with only three monthly extensions left, time pressure rises and potential targets gain negotiating leverage. Overall impact is neutral: cash safety maintained, but strategic uncertainty persists.

TL;DR � Repeated deadline pushes heighten execution risk; growing sponsor loan increases leverage against future proceeds.

The ninth consecutive extension underscores prolonged deal sourcing challenges, raising the probability of liquidation or shareholder fatigue. Each draw on the unsecured note—now at least $250k—adds liabilities senior to ordinary shareholders upon closing. With only three extensions remaining, investors should monitor note balance growth and any shift in sponsor commitment. From a risk viewpoint, the filing leans negative because timeline slippage and incremental debt can erode eventual transaction economics.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) ha presentato un modulo 8-K annunciando la nona proroga di un mese per completare una combinazione aziendale. Il Consiglio ha spostato la scadenza, nota come “Periodo di Combinazione Aziendale,� dal 5 agosto 2025 al 5 settembre 2025.

Per attuare la proroga, lo sponsor CGC II Sponsor LLC anticiperà 250.000 dollari tramite una nota di debito non garantita che consente prestiti fino a 2,4 milioni di dollari. I fondi saranno depositati nel conto fiduciario IPO come richiesto dal memorandum e dallo statuto modificati della società.

Questa è la 9ª delle 12 proroghe mensili consentite; non sono stati comunicati nuovi risultati finanziari, identificazione di target o altre operazioni rilevanti.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) presentó un formulario 8-K informando sobre su novena prórroga de un mes para completar una combinación de negocios. La Junta movió la fecha límite, conocida como el “Período de Combinación de Negocios,� del 5 de agosto de 2025 al 5 de septiembre de 2025.

Para efectuar la prórroga, el patrocinador CGC II Sponsor LLC adelantará 250,000 dólares bajo una nota promisoria no garantizada que permite préstamos de hasta 2.4 millones de dólares. Los fondos se depositarán en la cuenta fiduciaria de la IPO según lo requerido por el memorando y los estatutos enmendados de la compañía.

Esta es la 9ª de 12 prórrogas mensuales permitidas; no se reportaron nuevos resultados financieros, identificación de objetivos u otras transacciones materiales.

Cartesian Growth Corporation II (나스ë‹�: RENE/RENEU/RENEW)ê°€ 사업 ê²°í•© 완료ë¥� 위한 아홉 번째 í•� ë‹� 연장 사실ì� 8-K 보고서로 공시했습니다. ì´ì‚¬íšŒëŠ” ‘사ì—� ê²°í•© 기간â€� 마ê°ì¼ì„ 2025ë…� 8ì›� 5ì¼ì—ì„� 2025ë…� 9ì›� 5ì¼ë¡œ 연기했습니다.

연장ì� 실행하기 위해 스í°ì„� CGC II Sponsor LLCëŠ� 최대 240ë§� 달러까지 차입ì� 가능한 무담ë³� 약ì†ì–´ìŒìœ¼ë¡œ 25ë§� 달러ë¥� 선지급할 예정입니ë‹�. ì� ìžê¸ˆì€ 회사ì� 수정ë� ì •ê´€ ë°� ê°ì„œì—� ë”°ë¼ IPO ì‹ íƒê³„좌ì—� 입금ë©ë‹ˆë‹�.

ì´ë²ˆì� 허용ë� 12íš� ì¤� 9번째 월별 연장입니ë‹�; 추가 재무 ê²°ê³¼, 목표 ì‹ë³„ ë˜ëŠ” 기타 중요í•� 거래ëŠ� ë³´ê³ ë˜ì§€ 않았습니ë‹�.

Cartesian Growth Corporation II (Nasdaq : RENE/RENEU/RENEW) a déposé un formulaire 8-K révélant sa neuvième prolongation d’un mois pour finaliser une fusion d’entreprise. Le conseil d’administration a repoussé la date limite, appelée « Période de Fusion », du 5 août 2025 au 5 septembre 2025.

Pour effectuer cette prolongation, le sponsor CGC II Sponsor LLC avancera 250 000 dollars via un billet à ordre non garanti autorisant des emprunts jusqu’� 2,4 millions de dollars. Les fonds seront déposés sur le compte fiduciaire de l’IPO conformément au mémorandum et aux statuts modifiés de la société.

Il s’agit de la 9e des 12 prolongations mensuelles autorisées ; aucun résultat financier supplémentaire, identification de cible ou autre transaction importante n’a été rapporté.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) hat einen 8-K-Bericht eingereicht, in dem die neunte einmonatige Verlängerung zur Durchführung einer Unternehmenszusammenführung bekanntgegeben wird. Der Vorstand verschob die Frist, bekannt als „Business Combination Period�, vom 5. August 2025 auf den 5. September 2025.

Zur Durchführung der Verlängerung wird der Sponsor CGC II Sponsor LLC 250.000 US-Dollar über einen ungesicherten Schuldschein vorschießen, der Darlehen bis zu 2,4 Millionen US-Dollar erlaubt. Die Mittel werden auf das IPO-Treuhandkonto eingezahlt, wie es durch die geänderte Satzung des Unternehmens vorgeschrieben ist.

Dies ist die 9. von 12 zulässigen monatlichen Verlängerungen; keine weiteren Finanzergebnisse, Zielidentifikationen oder sonstigen wesentlichen Transaktionen wurden gemeldet.

0000927066false00009270662025-08-052025-08-05

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 Form 8-K 

 CURRENT REPORT
 Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (date of earliest event reported): August 5, 2025  


 
DAVITA INC.
(Exact name of registrant as specified in its charter)
 

DE1-1410651-0354549
(State or other jurisdiction
of incorporation)
(Commission File Number)(IRS Employer
Identification No.)
 
2000 16th Street
Denver,CO80202
(Address of principal executive offices including Zip Code)
 
(720) 631-2100
(Registrant’s telephone number, including area code)
 
Not applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class: Trading symbol(s):Name of each exchange on which registered:
Common Stock, $0.001 par value DVANew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 2.02. Results of Operations and Financial Condition.
 
On August 5, 2025, DaVita Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report.
 
The information contained in this Item 2.02 (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
Number
Description
99.1
Press Release dated August 5, 2025 announcing the registrant’s financial results for the quarter ended June 30, 2025.
104.0Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
DAVITA INC.
Date: August 5, 2025
By:/s/    Christopher M. Berry
Christopher M. Berry
Chief Accounting Officer



FAQ

Why did RENE/RENEW file this Form 8-K?

The company disclosed approval of its ninth one-month extension to complete a business combination and the related $250,000 sponsor deposit.

What is the new business-combination deadline for Cartesian Growth Corporation II?

The deadline was extended to September 5, 2025.

How much money is being added to the trust account?

$250,000 will be deposited by the sponsor under an unsecured promissory note.

How many extensions remain under the Articles?

Three one-month extensions remain; this was the 9th of 12 allowable extensions.

Does the filing mention any merger target or financial results?

No. The 8-K reports only the extension and related funding; no target or earnings data were provided.
Davita Inc

NYSE:DVA

DVA Rankings

DVA Latest News

DVA Latest SEC Filings

DVA Stock Data

10.62B
38.12M
49.51%
48.26%
7.77%
Medical Care Facilities
Services-misc Health & Allied Services, Nec
United States
DENVER